About Callisto Pharma Group
Callisto Pharma Group is a Healthcare company based in United Kingdom founded in 2003, and was acquired by ProductLife Group in October 2024. Pharmaceutical supply chain consultancy and technical support are provided. Its focus areas include Biopharma Outsourcing, Consulting and Regulatory Affairs.
Company details
Expertise in pharmaceutical supply chain operations is offered by Callisto Pharma Group, founded in 2003 and based in the United Kingdom. Services encompass product development, licensing, pharmacovigilance, batch certification, import release, and distribution. Regulatory affairs, GxP compliance, and Qualified Person functions are supported, along with technical transfers, manufacturing processes, and analytical troubleshooting for manufacturers and license holders. Additional assistance is extended to medical devices, borderline products, biocides, and food supplements.
- Headquarters United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website callistopharmagroup.com
- Acquired by ProductLife Group (Oct 2024)
- Investors
- Acquired byProductLife Group
(Oct 2024)
Investors in Callisto Pharma Group
Callisto Pharma Group has secured backing from 1 investor. Prominent investors backing the company include ProductLife Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Regulatory and pharmacovigilance support is provided for product lifecycles. | 2000 | productlifegroup.com | Suresnes, France |
Investor details for Callisto Pharma Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Callisto Pharma Group
12 people are tracked at Callisto Pharma Group (3 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
Jo Bunyan | Managing Director | Leadership |
Paul Bunyan | Operations Director | Leadership |
Jo Vallans | General Manager Regulatory & Pharmacovigilance | Leadership |
Sarah Bains | Senior Regulatory Executive | Team |
Isabelle Agar | Senior PV Executive | Team |
Claudia Citrolo | Deputy Regulatory Manager | Team |
Marie Walsh | Technical & Business Development Manager | Team |
Ollie Phillips | PV Executive | Team |
Ellie Bunyan | Pharmacovigilance Manager | Team |
Isobel Lee | PV Officer | Team |
David Wood | GDP Consultant | Team |
Charlie M. | Regulatory Manager | Team |
Complete people profiles for Callisto Pharma Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Callisto Pharma Group
2 dated milestones of Callisto Pharma Group across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Callisto Pharma Group is founded.
- Exit Acquired by ProductLife Group.
Web traffic of Callisto Pharma Group
The website of Callisto Pharma Group (callistopharmagroup.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 30% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Callisto Pharma Group
Callisto Pharma Group was founded in 2003.
Callisto Pharma Group is headquartered in United Kingdom.
Expertise in pharmaceutical supply chain operations is offered by Callisto Pharma Group, founded in 2003 and based in the United Kingdom. Services encompass product development, licensing, pharmacovigilance, batch certification, import release, and distribution. Regulatory affairs, GxP compliance, and Qualified Person functions are supported, along with technical transfers, manufacturing processes, and analytical troubleshooting for manufacturers and license holders. Additional assistance is extended to medical devices, borderline products, biocides, and food supplements.
Callisto Pharma Group has 1 investor. Key investors include ProductLife Group.
Yes. Callisto Pharma Group was acquired by ProductLife Group in October 2024.